Clinical trials recruiting in Daugavpils, Latvia
3
Recruiting trials
8
Conditions
Phase breakdown
Phase 3 3
Conditions recruiting in Daugavpils, Latvia
| Condition | Trials |
|---|---|
| Atrial Fibrillation (AF) | 1 |
| Atrial fibrillation | 1 |
| COPD | 1 |
| Cardiovascular Diseases | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Hypertension | 1 |
| Pulmonary Disease, Chronic Obstructive | 1 |
| Type 2 diabetes | 1 |
Recruiting trials in Daugavpils, Latvia
- Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Common questions
How many clinical trials are recruiting in Daugavpils, Latvia?
3 recruiting trials have at least one study site in Daugavpils, Latvia.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.